Filter
386
Filtered Results: 386
Text search:
M.
Muñoz
Featured
Recommendations
34
New Publications
51
Language
Document type
No document type
168
Studies & Reports
95
Guidelines
69
Manuals
28
Strategic & Response Plan
10
Fact sheets
9
Training Material
4
Situation Updates
2
Brochures
1
Countries / Regions
Latin America and the Carribbean
31
Colombia
15
Western and Central Europe
13
Chile
12
Kenya
10
Russia
10
Global
9
Germany
9
Rwanda
7
Eastern Europe
7
Brazil
7
Ecuador
7
Ukraine
6
Venezuela
6
Paraguay
6
India
6
Tanzania
5
Middle East and North Africa
5
South Africa
5
Malawi
4
Mozambique
4
Africa
4
Syria
3
Spain
3
Argentina
3
Ethiopia
3
Nepal
2
Nigeria
2
Zimbabwe
2
Philippines
2
Asia
2
South–East Asia Region
2
North America
2
East and Southern Africa
2
Thailand
1
El Salvador
1
Turkey
1
Ghana
1
Sierra Leone
1
China
1
Canada
1
Singapore
1
Senegal
1
Peru
1
Malaysia
1
USA
1
West and Central Africa
1
Japan
1
Portugal
1
Bolivia
1
Bangladesh
1
Vietnam
1
Moldova
1
Yemen
1
Mali
1
Angola
1
Botswana
1
South Sudan
1
Indonesia
1
Liberia
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
131
Clinical Guidelines
51
Public Health
15
Women & Child Health
14
Key Resources
7
Capacity Building
3
Pharmacy & Technologies
3
Toolboxes
Mental Health
56
COVID-19
52
NTDs
43
TB
42
HIV
22
Refugee
13
Planetary Health
12
Disability
10
Rapid Response
9
NCDs
6
Ebola & Marburg
5
Caregiver
5
Global Health Education
5
AMR
5
Zika
4
Pharmacy
3
Specific Hazards
1
Cholera
1
Social Ethics
1
Findings from a cross-sectional qualitative study of HIV vulnerabilities among People Who Inject Drugs and their sex partners in Bihar and Manipur, India. The study is one of the first qualitative comparative studies to seek an in-depth understanding of the vulnerabilities to HIV acquisition among P...
At present at least 2.2 billion people around the world have a vision impairment, of whom at least 1 billion have a vision impairment that could have been prevented or is yet to be addressed. The world faces considerable challenges in terms of eye care, including inequalities in the coverage and qua...
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga...
The report underscores that sexual and reproductive health and rights are often the first to be sacrificed during epidemics and that the gains of the past decade must be protected. The report also makes it clear that scarce resources must be focused on the most marginalized women and girls, includin...
This publication is based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring and end of life care. This publication addresses medical devices for six types of cancer: breast, cervical, colorectal, leukem...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or...
РУКОВОДСТВО ПО
ДОПОЛНЕНИЕ К СВОДНОМУ РУКОВОДСТВУ ПО УСЛУГАМ ТЕСТИРОВАНИЯ НА ВИЧ
ДЕКАБРЬ 2016 г.
УСЛУГИ ТЕСТИРОВАНИЯ НА ВИЧ
Revista De Investigación (de La Universidad Norbert Wiener) DOI: https://doi.org/10.37768/unw.rinv.10.01.009
La tuberculosis es una enfermedad infecciosa que suele afectar a los pulmones, causada por una bacteria (Mycobacterium tuberculosis). Se trasmite de una persona a otra a través d...
Human use of land has been transforming Earth's ecology for millennia. From hunting and foraging to burning the land to farming to industrial agriculture, increasingly intensive human use of land has reshaped global patterns of biodiversity, ecosystems, landscapes, and climate. This review examines ...
The ninth WHO report on the global tobacco epidemic tracks the progress made by countries in tobacco control since 2008 and, marks 15 years since the introduction of the MPOWER technical package which is designed to help countries implement the demand-reduction measures of the WHO Framework Conventi...
Las Infecciones Asociadas a la Atención en Salud (IAAS) son reconocidas en la
actualidad como un problema de salud pública y existen lineamientos guber-
namentales en la mayoría de los países para constituir sistemas de vigilancia y
Programas de Prevención y Control de Infecciones para con...
National HIV curriculum
You can always find the most up to date version of this document at
https://www.hiv.uw.edu/go/co-occurring-conditions/opportunistic-infections-prevention/coreconcept/all
Provide guidance to HIV care practitioners on the optimal use of antiretroviral (ARV) agents for the treatment of HIV infection in adults and adolescents.
The current document is anupdate of the guidelines developed by the EUCAST subcommittee on detection of resistance mechanisms. The EUCAST Steering Committee has carried out the current update. The document has been developed mainly for routine use in clinical laboratories and doesnot cover technical...
